Jonathan Norton

Deprescribing Education vs Usual Care for Patients with Cognitive Impairment and Primary Care Clinicians: The OPTIMIZE Pragmatic Cluster Randomized Trial

Elizabeth Bayliss, MD, MSPHSenior Investigator, Institute for Health Research, Kaiser Permanente ColoradoProfessor of Family Medicine, University of Colorado School of MedicineIMPACT Health Care Systems (HCS) CoreUSDeN Data and Resources Core Co-LeaderUSDeN Measures Working Group Leader Cynthia Boyd, MD, MPHDirector, Division of Geriatric Medicine and GerontologyProfessor of Medicine, Epidemiology and Health Policy and ManagementJohns Hopkins University …

Deprescribing Education vs Usual Care for Patients with Cognitive Impairment and Primary Care Clinicians: The OPTIMIZE Pragmatic Cluster Randomized Trial Read More »

USDeN Call for Pilot Studies Preparatory to Large Clinical Trials

Complementary and Integrative Health Interventions to Support Deprescribing of Benzodiazepine Receptor Agonists in Older Adults The US Deprescribing Research Network (USDeN) will soon be seeking applications for large pilot studies that test complementary and integrative health approaches to support deprescribing of benzodiazepine receptor agonists in older adults. The goal of this program is to support …

USDeN Call for Pilot Studies Preparatory to Large Clinical Trials Read More »

Describing deprescribing: How do GPs discuss deprescribing topics with their patients, and how in-depth do they go?

Thompson W, Jarbøl D, Nielsen JB, Haastrup P, Pedersen LB. GP preferences for discussing statin deprescribing: a discrete choice experiment. Fam Pract. 2022;39(1):26-31. doi:10.1093/fampra/cmab075 Although there is ample evidence on the benefits of deprescribing for older patients, providers’ deprescribing-related communication preferences are less understood. Given that clinicians often have the greatest influence on patients’ deprescribing …

Describing deprescribing: How do GPs discuss deprescribing topics with their patients, and how in-depth do they go? Read More »

New Cohort of Junior Investigators Selected!

We are thrilled to announce our 2022-2023 cohort of Junior Investigator Intensive Awardees. The Junior Investigator Intensive program provides dedicated supports and research learning opportunities to help fellows, post-docs, and early-stage faculty succeed with their deprescribing-related research and advance their research careers. This years cohort awardees include 13 outstanding physician, pharmacist, and PhD investigators from …

New Cohort of Junior Investigators Selected! Read More »

Beyond Study Design and Primary Outcomes: Lessons Learned from a Deprescribing Trial to Increase Cognitive Reserve

Presenter: Dr. Daniela Moga is an Associate Professor and Larry H. Spears Endowed Chair in Pharmacogenetics in the College of Pharmacy at University of Kentucky. April 12, 2022 | 2PM ET / 11AM PT The course of Alzheimer’s disease (AD) includes a 10–20-year preclinical period with progressive accumulation of amyloid β plaques and neurofibrillary tangles …

Beyond Study Design and Primary Outcomes: Lessons Learned from a Deprescribing Trial to Increase Cognitive Reserve Read More »

Deprescribing and Delirium, Co-hosted by USDeN and NIDUS

Presenter: Noll. L. Campbell, PharmD, MS, Assistant Professor of Pharmacy Practice at Purdue University College of Pharmacy Moderator: Sharon K. Inouye, MD, MPH, Professor of Medicine, Director of the Aging Brain Center at the Marcus Institute for Aging Research at Harvard Medical School, Hebrew SeniorLife January 18, 2022 | 2PM ET / 11AM PT Several medications have long …

Deprescribing and Delirium, Co-hosted by USDeN and NIDUS Read More »

The Drive to Deprescribe Initiative – Optimizing Medication Use in the Post-Acute and Long-Term Care Setting

Presenter(s): Dr. Jennifer Pruskowski, PharmD, MS, BCPS, BCGP – Associate Director for Education and Evaluation, Pittsburgh Geriatric Research Education and Clinical Center, Pittsburgh Veterans Affairs Healthcare System Dr. Arif Nazir, MD, FACP, CMD, AGSF – Chief Medical Officer for Signature Healthcare in Louisville, Kentucky, Founder and Chief Medical Officer for Care Ascend Dr. Chad Worz, …

The Drive to Deprescribe Initiative – Optimizing Medication Use in the Post-Acute and Long-Term Care Setting Read More »

Contact Us

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.